Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net revenues
Operating expenses        
General and administrative 1,278 1,471 4,896 2,341
Total operating expenses 1,278 1,471 4,896 2,341
Net loss from operations (1,278) (1,471) (4,896) (2,341)
Interest expense, net (140) (389) (271) (480)
Loss on remeasurement of derivative liability (11) (238)
Gain on extinguishment of debt 191 191
Equity income from DNA X LLC 48
Net loss from continuing operations before income taxes (1,238) (1,860) (5,166) (2,821)
Income tax benefit from continuing operations
Net loss from continuing operations (1,238) (1,860) (5,166) (2,821)
Discontinued operations        
Income (loss) from discontinued operations (9) (5,615) 10,259 (4,196)
Net income (loss) $ (1,247) $ (7,475) $ 5,093 $ (7,017)
Net income (loss) per share basic and diluted:        
Net loss per share basic, Continuing operations [1] $ (0.91) $ (3.52) $ (3.95) $ (6.61)
Net loss per share diluted, Continuing operations [1] (0.91) (3.52) (3.95) (6.61)
Net loss per share basic, Discontinued operations [1] (0.01) (10.63) 7.84 (9.82)
Net loss per share diluted, Discontinued operations [1] (0.01) (10.63) 7.84 (9.82)
Net loss per share basic, Net loss [1] (0.92) (14.15) 3.89 (16.43)
Net loss per share diluted, Net loss [1] $ (0.92) $ (14.15) $ 3.89 $ (16.43)
Weighted-average shares used in computing net income (loss) per share:        
Basic 1,350,914 528,367 1,308,227 426,962
Diluted 1,350,914 528,367 1,308,227 426,962
[1] Adjusted retroactively to reflect the 1-for-18 reverse stock split that became effective on October 28, 2025, see Note 1.